Resveratrol activation of SIRT1/MFN2 can improve mitochondria function, alleviating doxorubicin‐induced myocardial injury

Background Doxorubicin is a widely used cytotoxic chemotherapy agent for treating different malignancies. However, its use is associated with dose-dependent cardiotoxicity, causing irreversible myocardial damage and significantly reducing the patient's quality of life and survival. In this study, an animal model of doxorubicin-induced cardiomyopathy was used to investigate the pathogenesis of doxorubicin-induced myocardial injury. This study also investigated a possible treatment strategy for alleviating myocardial injury through resveratrol therapy in vitro. Methods Adult male C57BL/6J mice were randomly divided into a control group and a doxorubicin group. Body weight, echocardiography, surface electrocardiogram, and myocardial histomorphology were measured. The mechanisms of doxorubicin cardiotoxicity in H9c2 cell lines were explored by comparing three groups (phosphate-buffered saline, doxorubicin, and doxorubicin with resveratrol). Results Compared to the control group, the doxorubicin group showed a lower body weight and higher systolic arterial pressure, associated with reduced left ventricular ejection fraction and left ventricular fractional shortening, prolonged PR interval, and QT interval. These abnormalities were associated with vacuolation and increased disorder in the mitochondria of cardiomyocytes, increased protein expression levels of α-smooth muscle actin and caspase 3, and reduced protein expression levels of Mitofusin2 (MFN2) and Sirtuin1 (SIRT1). Compared to the doxorubicin group, doxorubicin + resveratrol treatment reduced caspase 3 and manganese superoxide dismutase, and increased MFN2 and SIRT1 expression levels. Conclusion Doxorubicin toxicity leads to abnormal mitochondrial morphology and dysfunction in cardiomyocytes and induces apoptosis by interfering with mitochondrial fusion. Resveratrol ameliorates doxorubicin-induced cardiotoxicity by activating SIRT1/MFN2 to improve mitochondria function

Resveratrol activation of SIRT1/MFN2 can improve mitochondria function, alleviating doxorubicin‐induced myocardial injury

Background: Doxorubicin is a widely used cytotoxic chemotherapy agent for treating different malignancies. However, its use is associated with dose‐dependent cardiotoxicity, causing irreversible myocardial damage and significantly reducing the patient's quality of life and survival. In this study, an animal model of doxorubicin‐induced cardiomyopathy was used to investigate the pathogenesis of doxorubicin‐induced myocardial injury. This study also investigated a possible treatment strategy for alleviating myocardial injury through resveratrol therapy in vitro. Methods: Adult male C57BL/6J mice were randomly divided into a control group and a doxorubicin group. Body weight, echocardiography, surface electrocardiogram, and myocardial histomorphology were measured. The mechanisms of doxorubicin cardiotoxicity in H9c2 cell lines were explored by comparing three groups (phosphate‐buffered saline, doxorubicin, and doxorubicin with resveratrol). Results: Compared to the control group, the doxorubicin group showed a lower body weight and higher systolic arterial pressure, associated with reduced left ventricular ejection fraction and left ventricular fractional shortening, prolonged PR interval, and QT interval. These abnormalities were associated with vacuolation and increased disorder in the mitochondria of cardiomyocytes, increased protein expression levels of α‐smooth muscle actin and caspase 3, and reduced protein expression levels of Mitofusin2 (MFN2) and Sirtuin1 (SIRT1). Compared to the doxorubicin group, doxorubicin + resveratrol treatment reduced caspase 3 and manganese superoxide dismutase, and increased MFN2 and SIRT1 expression levels. Conclusion: Doxorubicin toxicity leads to abnormal mitochondrial morphology and dysfunction in cardiomyocytes and induces apoptosis by interfering with mitochondrial fusion. Resveratrol ameliorates doxorubicin‐induced cardiotoxicity by activating SIRT1/MFN2 to improve mitochondria function

Fire resistance test of transformers filled with natural ester insulating liquid

Natural ester fluids, as a renewable, biodegradable liquid dielectric, its flash point is above 300°C, and the burning point exceeds 330°C, high flash point liquids known as ‘less flammable’ liquids. There is a possibility applying the natural ester fluid immersed transformer instead of dry type transformer in high fire resistance requirement occasion. In order to verify the fire resistance of natural ester insulating oil transformer, set forth a series of contrast test between natural ester insulating oil and mineral insulating oil, including flash point, burning point, explosion limits, metal hot surface test, and burning plate test. Through developing burning test platform of transformer to launch the burning test for 10 kV transformer of natural ester insulating oil. The results show that the transformer filled with natural ester fluid cannot burn for 30 min in the case of severe external fire, which provides a relatively abundant time for fire extinguishing and has certain fireproof performance. In addition, by improving the mechanical strength of transformer tank, install the specific pressure relief devices and using high temperature seal, bushing etc., which can improve the fire resistance of transformers filled with natural ester insulating fluids

Influence of Microgravity on the Concentration of Circulating Primordial Germ Cells in Silky Chicken Offspring

This study was performed to examine the implications of microgravity on circulating primordial germ cells (PGCs) of the offspring of silky chickens at stages 13 to 17. China's ShenZhou-3 unmanned spaceship was launched on March 25, 2002, at 22: 00 Beijing time (14: 00GMT). The spaceship carried nine fertilized silky chicken eggs (F0) to test the reliability of the life-support system in the space environment. One female and two male chickens were born from these eggs. The three chickens mated naturally and F1 fertilized eggs were collected. Blood was collected from the dorsal aorta or the marginal vein of the embryos at stages 13 to 17, and the number of circulating PGCs of F1 offspring was counted. A similar experimental protocol was performed for the control group (C1 and C2 group). No differences were observed except at stage 15, when the F1 offspring of the flight group (F0 group) showed higher PGC concentrations than the other treatment groups. These results indicated that microgravity may have little effect on the migration and concentration of PGCs in F1 offspring, perhaps because the flight chickens were raised to maturity on Earth under a gravity of 1×g and had sufficient time to recover. Thus, microgravity appeared to have little effect on the PGC concentrations of F1 offspring of silky chickens during circulating stages 13 to 17